Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Adalimumab (Subcutaneous Route)
Drug Information provided by: MicromedexUS Brand Names
|
Description
Adalimumab is used to decrease signs, symptoms, and progression of moderately to severely active rheumatoid arthritis and ankylosing spondylitis. It is also used to treat psoriatic arthritis which is a type of arthritis that causes pain and swelling of the joints and patches of scaly skin on some areas of the body. Psoriatic arthritis is related to the skin condition, psoriasis. Adalimumab can be used in combination with methotrexate or other Disease Modifying Antirheumatic Drugs (DMARDs).
Adalimumab is also used to decrease signs and symptoms of Crohn's disease in patients who have not been helped by other medicines, such as infliximab.
This medicine may also be used to treat moderate to severe chronic plaque psoriasis.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
- Solution
